News articles for ZeaVision, LLC:
Thursday, February 9, 2012
Eye Vitamin Pioneer Promotes New Science for AMD Awareness Month
ST. LOUIS, Feb. 9, 2012 /PRNewswire/ -- EyePromise launched a new website for AMD Awareness Month to enhance education of the role of nutrition in managing AMD risk.
Directed toward consumers and EyeCare Professionals, AMDAwarenessMonth.com allows visitors to learn about Age-Related Macular Degeneration, receive ...
read more Thursday, January 19, 2012
ZeaVision Earns NSF International Certified for Sport® Designation
ST. LOUIS, Jan. 19, 2012 /PRNewswire/ -- ZeaVision's entire family of EyePromise® supplements, including the new EyePromise vizual EDGE product, which is designed to help athletes both see better and react faster, are now certified under the NSF International's Certified for Sport® program. This is the first group of vision ...
read more Wednesday, November 30, 2011
Thursday, November 10, 2011
Study Shows Zeaxanthin Improves Vision in Elderly
ST. LOUIS, Nov. 10, 2011 /PRNewswire/ -- A recent study published in the November 2011 Journal of Optometry confirms improved vision in elderly patients through nutritional supplementation. The Zeaxanthin (zee-uh-zan-thin) and Visual Function Study (ZVF), conducted by eye nutrition pioneer Stuart Richer, PhD, OD at the Veterans Administration Hospital in ...
read more Friday, October 28, 2011
ZeaVision Celebrates 10-Year Anniversary
ST. LOUIS, Oct. 28, 2011 /PRNewswire/ -- ZeaVision, LLC, makers of EyePromise® eye vitamins, is celebrating its 10-year anniversary. In 2001, Dennis Gierhart, PhD, co-founded the company with a singular mission: to fight vision loss and preserve healthy vision through superior science-based nutraceuticals and macular pigment measurement technology.
ZeaVision's ...
read more Monday, October 24, 2011
Three Hits in the Fight Against Age-Related Macular Degeneration
ST. LOUIS, Oct. 24, 2011 /PRNewswire/ -- St. Louis-based ZeaVision, LLC announced that three recent groundbreaking studies demonstrate that Zeaxanthin (zee-uh-zan-thin), the predominate protective pigment in the back of the eye, reduces the risk for Age-Related Macular Degeneration (AMD) and benefits the treatment of advanced AMD, a condition that destroys ...
read more Friday, September 30, 2011